126 related articles for article (PubMed ID: 2060177)
1. Statural growth and skeletal maturation in rheumatic prepubertal children treated with a third generation glucocorticoid (deflazacort) versus prednisone. An interim study.
Vignolo M; Milani S; Imbimbo B; Naselli A; Di Battista E; Piaggio G; Leveratto L; Morreale G; Sardella ML; Corsini M
Clin Exp Rheumatol; 1991; 9 Suppl 6():41-5. PubMed ID: 2060177
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent effects of deflazacort and prednisone on growth and skeletal maturation.
Aicardi G; Benso L; Vignolo M; Terragna A; Verrina E; Cordone G; Coppo R; Sernia O; Sardella ML; Di Battista E
Br J Rheumatol; 1993 May; 32 Suppl 2():39-43. PubMed ID: 8495279
[TBL] [Abstract][Full Text] [Related]
3. Comparison of growth retarding effects induced by two different glucocorticoids in prepubertal sick children: an interim long-term analysis.
Aicardi G; Milani S; Imbimbo B; Vignolo M; Di Battista E; Gusmano R; Terragna A; Cordone G; Cottafava F; Coppo R
Calcif Tissue Int; 1991 Apr; 48(4):283-7. PubMed ID: 2059880
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort.
Loftus J; Allen R; Hesp R; David J; Reid DM; Wright DJ; Green JR; Reeve J; Ansell BM; Woo PM
Pediatrics; 1991 Sep; 88(3):428-36. PubMed ID: 1881719
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth.
Balsan S; Stéru D; Bourdeau A; Grimberg R; Lenoir G
Calcif Tissue Int; 1987 Jun; 40(6):303-9. PubMed ID: 3111667
[TBL] [Abstract][Full Text] [Related]
6. Deflazacort in juvenile chronic arthritis.
Loftus JK; Reeve J; Hesp R; David J; Ansell BM; Woo PM
J Rheumatol Suppl; 1993 Apr; 37():40-2. PubMed ID: 8501751
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.
Olgaard K; Storm T; van Wowern N; Daugaard H; Egfjord M; Lewin E; Brandi L
Calcif Tissue Int; 1992 Jun; 50(6):490-7. PubMed ID: 1525702
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two glucocorticoid preparations (deflazacort and prednisone) in the treatment of immune-mediated diseases.
Scudeletti M; Puppo F; Lanza L; Mantovani L; Bosco O; Iudice A; Imbimbo B; Indiveri F
Eur J Clin Pharmacol; 1993; 45 Suppl 1():S29-34. PubMed ID: 8313931
[TBL] [Abstract][Full Text] [Related]
9. Long-term therapy with the new glucocorticosteroid deflazacort in rheumatoid arthritis. Double-blind controlled randomized 12-months study against prednisone.
Eberhardt R; Krüger K; Reiter W; Gross W; Zwingers T
Arzneimittelforschung; 1994 May; 44(5):642-7. PubMed ID: 8024639
[TBL] [Abstract][Full Text] [Related]
10. A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: prednisone versus deflazacort.
LoCascio V; Ballanti P; Milani S; Bertoldo F; LoCascio C; Zanolin EM; Bonucci E
Calcif Tissue Int; 1998 Mar; 62(3):199-204. PubMed ID: 9501951
[TBL] [Abstract][Full Text] [Related]
11. Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis.
Messina OD; Barreira JC; Zanchetta JR; Maldonado-Cocco JA; Bogado CE; Sebastián ON; Flores D; Riopedre AM; Redondo G; Lázaro A
J Rheumatol; 1992 Oct; 19(10):1520-6. PubMed ID: 1464862
[TBL] [Abstract][Full Text] [Related]
12. The long-term efficacy and safety of two different corticosteroids in chronic sarcoidosis.
Rizzato G; Riboldi A; Imbimbo B; Torresin A; Milani S
Respir Med; 1997 Sep; 91(8):449-60. PubMed ID: 9338047
[TBL] [Abstract][Full Text] [Related]
13. Deflazacort. A review of its pharmacological properties and therapeutic efficacy.
Markham A; Bryson HM
Drugs; 1995 Aug; 50(2):317-33. PubMed ID: 8521761
[TBL] [Abstract][Full Text] [Related]
14. Growth charts, growth velocity and bone development in childhood obesity.
De Simone M; Farello G; Palumbo M; Gentile T; Ciuffreda M; Olioso P; Cinque M; De Matteis F
Int J Obes Relat Metab Disord; 1995 Dec; 19(12):851-7. PubMed ID: 8963351
[TBL] [Abstract][Full Text] [Related]
15. A controlled study of deflazacort in the treatment of idiopathic nephrotic syndrome.
Broyer M; Terzi F; Lehnert A; Gagnadoux MF; Guest G; Niaudet P
Pediatr Nephrol; 1997 Aug; 11(4):418-22. PubMed ID: 9260237
[TBL] [Abstract][Full Text] [Related]
16. Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids.
Montecucco C; Caporali R; Caprotti P; Caprotti M; Notario A
J Rheumatol; 1992 Dec; 19(12):1895-900. PubMed ID: 1294736
[TBL] [Abstract][Full Text] [Related]
17. Effect of deflazacort versus methylprednisone on growth, body composition, lipid profile, and bone mass after renal transplantation. The Deflazacort Study Group.
Ferraris JR; Pasqualini T; Legal S; Sorroche P; Galich AM; Pennisi P; Domene H; Jasper H
Pediatr Nephrol; 2000 Jul; 14(7):682-8. PubMed ID: 10912543
[TBL] [Abstract][Full Text] [Related]
18. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
Cacoub P; Chemlal K; Khalifa P; Wechsler B; De Gennes C; Belmatoug N; Cohen P; Ziza JM; Verdoncq B; Piette JC
J Rheumatol; 2001 Nov; 28(11):2474-9. PubMed ID: 11708421
[TBL] [Abstract][Full Text] [Related]
19. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
[TBL] [Abstract][Full Text] [Related]
20. Experience with deflazacort in children and adolescents after renal transplantation.
Schärer K; Feneberg R; Klaus G; Paschen C; Wüster C; Mehls O; Schaefer F
Pediatr Nephrol; 2000 Jun; 14(6):457-63. PubMed ID: 10872183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]